Commentary & Deal Flow

+++Corrects: Laboratoire Eimer to sr notes (not sr sec notes)+++

Biogroup EUR1bn 144A/Reg S 2-part. Via JPM (B&D)/BNP/Natixis joint glocos/Citi/CA/DB/GS/HSBC joint books. List Lux. NY law.

     - CAB EUR750m sr sec notes due 2028 (7y). NC3 (50%,25%,par). Exp B2/B-/B+. Special call: 10% per year the 1st 3 years at 103. IPT mid to high 3s.

     - Laboratoire Eimer EUR250m sr notes due 2029 (8y). NC3 (50%,25%,par). Exp Caa1/CCC/CCC+. IPT mid 5s.

    Did investor call at 10am UKT today. Virtual meetings available today through Weds. UOP: along with a new EUR1.5bn term loan and EUR80m cash on hand, to repay its existing EUR2.015bn term loan, existing EUR305m 2nd lien debt and existing EUR219m PIK notes. Biz: Leading private medical laboratory testing business in France and Belgium.